VISTAGEN THERAPEUTICS INC (VTGN)
US92840H4002 - Common Stock
Vistagen to Present at the Stifel 2024 Healthcare Conference
Vistagen Reports Fiscal Year 2025 Second Quarter Financial Results and Corporate Update
Vistagen to Present at the 2024 Neuroscience Education Institute Congress
BioMedNewsBreaks — Vistagen Therapeutics Inc. (NASDAQ: VTGN) Releases Q1 2025 Financial, Corporate Report
Vistagen Therapeutics (NASDAQ: VTGN), a late clinical-stage, neuroscience-focused biopharmaceutical company dedicated to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on nose-to-brain neurocircuitry, is reporting its financial results for the first quarter 2025, or the period ended June 30, 2024. The report also included a status update on the company’s […]
VTGN Stock Earnings: VistaGen Therapeutics Beats EPS, Misses Revenue for Q1 2025
VTGN stock results show that VistaGen Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2025.
VTGN Stock Earnings: VistaGen Therapeutics Beats EPS, Misses Revenue for Q1 2025
InvestorPlace - Stock Market News, Stock Advice & Trading Tips VistaGen Therapeutics (NASDAQ:VTGN) just reported results for the first quarter...
Vistagen Reports Fiscal Year 2025 First Quarter Financial Results and Corporate Update
3 Stocks Under $15 That Could Make You a Millionaire
Investors looking for millionaire status in the coming years should consider three stocks under $15 that could be worth buying.
VTGN Stock Earnings: VistaGen Therapeutics Beats EPS, Misses Revenue for Q4 2024
VTGN stock results show that VistaGen Therapeutics beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2024.
Vistagen Reports Fiscal Year 2024 Financial Results and Provides Corporate Update
Vistagen to Present at the Jefferies Global Healthcare Conference
VistaGen Therapeutics Becomes Oversold (VTGN)
3 Must-Have Penny Stocks to Boost Your 2024 Portfolio
Though volatility remains high, these penny stocks promise significant returns, especially in this high-interest rate economic climate.
Meme Stock Rebound: 3 Reddit Favorites Primed for a Resurgence
The internet and forums such as Reddit, are rife with misinformation about stock prospects. However, these three might have potential.
Vistagen to Present at the 2024 RBC Capital Markets Global Healthcare Conference
7 Stocks Under $15 Predicted to Boom in the Next 2 Years
Discover seven promising stocks priced under $15, leading in sectors like financial services, biotechnology, and energy.
Millionaire Makers: 3 Stocks Under $10 Set to Skyrocket by 2027
Explore three stocks under $10 in electronic equipment and instruments, technology hardware, storage and peripherals, and biotechnology.
Vistagen to Present at the 2024 Anxiety and Depression Association (ADAA) Conference
Secret Superstars: 3 Unknown Stocks to Turn $5K into $100K by 2027
Learn the potency of lesser-known stocks and explore their fundamental edge in technology distribution, food retail, and biotechnology.
Vistagen to Present at Stifel 2024 Virtual CNS Days
Vistagen to Present at TD Cowen 44th Annual Health Care Conference
3 Revolutionary Biotech Stocks Poised for 10X Surge
Discover three biotech stocks set to soar in a $3.08 trillion market, merging medical innovations with financial growth opportunities.
3 Hidden-Gem Biotech Stocks Ready to Ride a Massive Market Wave
Explore hidden-gem biotech stocks set for growth in a booming market. Uncover top picks ready to redefine healthcare innovation.
Vistagen Therapeutics files for $350M mixed shelf (NASDAQ:VTGN)
Vistagen Therapeutics files a prospectus for mixed shelf offering of up to $350M, but it's not an offer to sell securities.
3 Penny Stocks to Buy for the Next Bull Run: February 2024
As the market pivots in 2024, dive into the dynamic world of penny stocks, revealing the top choices for February's exhilarating bull run.